Relationship of triglyceride-glucose index with chronic limb-threatening ischemia in lower extremity peripheral artery disease

被引:4
|
作者
Pala, Arda Aybars [1 ]
Urcun, Yusuf Salim [1 ]
机构
[1] Adiyaman Training & Res Hosp, Dept Cardiovasc Surg, Yunus Emre,1164 St 13, TR-02200 Adiyaman, Turkey
关键词
Chronic limb-threatening ischemia; insulin resistance; peripheral artery disease; triglyceride-glucose index;
D O I
10.1177/17085381211018332
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objectives Triglyceride-glucose index (TyG index), which is defined as the simple and novel marker of insulin resistance, is becoming increasingly important as a promising predictive marker for atherosclerotic diseases. Chronic limb-threatening ischemia is defined as the most advanced stage of the lower extremity peripheral artery disease, whose main cause is atherosclerosis and is associated in this respect with amputation, impaired quality of life, and mortality. The main purpose of the present study was to investigate the relation between the calculated TyG index values and chronic limb-threatening ischemia development. Methods A total of 296 patients who were diagnosed with lower extremity peripheral artery disease in our outpatient clinic between October 2018 and October 2020 were included in this study retrospectively. Two groups were formed by clinically staging the patients according to Rutherford Classification. Patients who did not develop chronic limb-threatening ischemia were classified as "Group 1" (n = 224) and those who developed were classified as "Group 2" (n = 72). Results The mean TyG index values that were calculated in Group 2 were significantly higher than in Group 1 (9.27 +/- 0.31 vs. 9.00 +/- 0.34, p < 0.001). In the multivariate logistic regression analysis conducted to determine the predictors of chronic limb-threatening ischemia development, C-reactive protein (OR [Odds Ratio]: 1.220, 95% CI [confidence interval]: 1.092-1.363, p < 0.001), high-density lipoprotein cholesterol (OR: 0.775, 95% CI: 0.715-0.839, p < 0.001) and TyG index (OR: 5.796, 95% CI: 2.050-16.382, p = 0.001) were identified as independent predictors. Receiver operating characteristic analysis revealed that the cut-off value of TyG index was 9.13 (area under the curve: 0.721, p < 0.001) with 70.8% sensitivity and 65.2% specificity. The TyG index was significantly correlated with Rutherford category, high-density lipoprotein cholesterol and mean platelet volume. Conclusions Chronic limb-threatening ischemia development may be predicted with the TyG index value, which is calculated easily from routine biochemical parameters, in patients diagnosed with lower extremity peripheral artery disease.
引用
收藏
页码:455 / 462
页数:8
相关论文
共 50 条
  • [31] Outcomes of lower extremity arterial bypass using the Human Acellular Vessel in patients with chronic limb-threatening ischemia
    Cifuentes, Sebastian
    Sen, Indrani
    Shuja, Fahad
    Mendes, Bernardo C.
    Colglazier, Jill J.
    Schaller, Melinda S.
    Kalra, Manju
    Morrison, Jonathan J.
    Demartino, Randall R.
    Rasmussen, Todd E.
    JOURNAL OF VASCULAR SURGERY, 2024, 79 (02)
  • [32] Different Lower Extremity Arterial Calcification Patterns in Patients with Chronic Limb-Threatening Ischemia Compared with Asymptomatic Controls
    Konijn, Louise C. D.
    Takx, Richard A. P.
    Mali, Willem P. Th. M.
    Veger, Hugo T. C.
    van Overhagen, Hendrik
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (06):
  • [33] Impact of Modified H2FPEF Score on Chronic Limb-Threatening Ischemia in Patients With Lower Extremity Artery Disease Who Underwent Endovascular Therapy
    Shikama, Taku
    Otaki, Yoichiro
    Watanabe, Tetsu
    Takahashi, Hiroki
    Kurokawa, Tasuku
    Tamura, Harutoshi
    Kato, Shigehiko
    Nishiyama, Satoshi
    Arimoto, Takanori
    Watanabe, Masafumi
    CIRCULATION REPORTS, 2022, 4 (08) : 378 - 387
  • [34] Effect of postoperative antithrombotic therapy on lower extremity outcomes after infrapopliteal bypass for chronic limb-threatening ischemia
    Marcaccio, Christina L.
    Patel, Priya B.
    Wang, Sophie
    Rastogi, Vinamr
    Moreira, Carla C.
    Siracuse, Jeffrey J.
    Schermerhorn, Marc L.
    Stangenberg, Lars
    JOURNAL OF VASCULAR SURGERY, 2022, 75 (05) : 1696 - +
  • [35] The Role of Endovascular Procedure for Peripheral Arterial Disease in Diabetic Patients With Chronic Limb-Threatening Ischemia
    Santosa, Yudistira
    Harca, Azizah Dhena
    Sukmaja, Edwin
    Yuwono, Angelina
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [36] Simultaneous Hybrid Treatment of Multilevel Peripheral Arterial Disease in Patients with Chronic Limb-Threatening Ischemia
    Pecoraro, Felice
    Pakeliani, David
    Bruno, Salvatore
    Dinoto, Ettore
    Ferlito, Francesca
    Mirabella, Domenico
    Lachat, Mario
    Cudia, Bianca
    Bajardi, Guido
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (13)
  • [37] Triglyceride Glucose Index in Peripheral Artery Disease
    Ozbay, Mustafa
    Abdelmottaleb, Wael
    ANGIOLOGY, 2023, 74 (03) : 297 - 297
  • [38] Regarding "Comparison of lower extremity bypass and peripheral vascular intervention for chronic limb-threatening ischemia in the Medicare-linked Vascular Quality Initiative"
    Hertzer, Norman R.
    JOURNAL OF VASCULAR SURGERY, 2024, 79 (02) : 455 - 456
  • [39] Triglyceride-Glucose Index Association With Severity of Coronary Artery Disease
    Soflaei, Sara Saffar
    Salehi-Sangani, Pooria
    Fallahi, Zahra
    Imanparast, Fatemeh
    Marousi, Mahdieh
    Tajfard, Mohammad
    Ferns, Gordon A.
    Moohebati, Mohsen
    Ghayour-Mobarhan, Majid
    ENDOCRINOLOGY DIABETES & METABOLISM, 2025, 8 (02)
  • [40] A novel, microvascular evaluation method and device for early diagnosis of peripheral artery disease and chronic limb-threatening ischemia in individuals with diabetes
    Matheson, Benjamin T.
    Osofsky, Robin B.
    Friedrichsen, Debra M.
    Brooks, Bill J.
    Giacolone, Joseph
    Khotan, Mehdy
    Shekarriz, Reza
    Pankratz, Vernon Shane
    Lew, Eric J.
    Clark, Ross M.
    Kanagy, Nancy L.
    JOURNAL OF VASCULAR SURGERY CASES INNOVATIONS AND TECHNIQUES, 2023, 9 (02):